Earnings Feed
Start Free
Lexaria Bioscience Corp.·4

Jan 10, 11:52 AM ET

BUNKA CHRISTOPHER 4

4 · Lexaria Bioscience Corp. · Filed Jan 10, 2025

Insider Transaction Report

Form 4
Period: 2025-01-07
Lexaria Bioscience Corp.LEXX
BUNKA CHRISTOPHER
Director
Transactions
  • Award

    Restricted Stock Award

    2025-01-07+100,000→ 373,543 total
Holdings

  • common shares

    (indirect: Private Holding Company)
    254,412

  • Warrants

    (indirect: Private Holding Company)
    Exercise: $10.50From: 2020-05-06Exp: 2025-05-06→ Common Shares (6,667 underlying)
    6,667

  • Stock Options

    Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (30,000 underlying)
    131,001

  • Stock Options

    Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (49,500 underlying)
    180,501

  • common shares

    273,543

  • Stock Options

    Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (26,000 underlying)
    32,667

  • Stock Options

    Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (23,334 underlying)
    56,001

  • Stock Options

    Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (15,000 underlying)
    71,001

  • Stock Options

    Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (30,000 underlying)
    101,001
Footnotes (2)
  • [F1]Beneficial ownership reflects the aggregate securities held directly.
  • [F2]The closing price on the Issuer's shares on the date of grant was $2.24.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT